Susquehanna Fundamental Investments, LLC Sutro Biopharma, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $6.94 Billion
- Q1 2025
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 37,956 shares of STRO stock, worth $30,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,956
Previous 87,810
56.77%
Holding current value
$30,744
Previous $161,000
85.09%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding STRO
# of Institutions
119Shares Held
60.6MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$6.04 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$5.6 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$4.41 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.43MShares$3.59 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$3.56 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $42.3M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...